Max Healthcare to Participate in Two Investor Conferences in February 2026
Max Healthcare Institute Limited will participate in the Nuvama India Conference on February 9, 2026, and the Kotak Chasing Growth Conference on February 23, 2026. Both events will be held physically in Mumbai and will include one-on-one and group meetings. No unpublished price-sensitive information will be shared.
Participation in investor conferences is a standard practice for listed companies to engage with stakeholders. This announcement does not contain any material price-sensitive information or significant business updates that would likely cause a substantial impact on the company's stock.
The announcement is a routine disclosure about the company's participation in investor conferences and does not contain any new financial information or strategic developments that would positively or negatively impact the stock.
Max Healthcare Institute Limited announced its participation in two upcoming investor conferences. The company's Chairman and Managing Director, along with senior management, will attend these events.
The first conference is the Nuvama India Conference 2026, scheduled for Monday, February 9, 2026, at the Grand Hyatt in Mumbai. This will involve one-on-one and group meetings in a physical format.
The second event is the 17th Kotak Chasing Growth Conference 2026, also to be held physically at the Grand Hyatt, Mumbai, on Monday, February 23, 2026. Similar to the first conference, it will include one-on-one and group meetings.
Max Healthcare noted that the schedule is subject to change and no unpublished price-sensitive information will be disclosed during these conferences. This disclosure will also be available on the company's website.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.